» Articles » PMID: 24796533

Phenotypic T Cell Exhaustion in a Murine Model of Bacterial Infection in the Setting of Pre-existing Malignancy

Overview
Journal PLoS One
Date 2014 May 7
PMID 24796533
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

While much of cancer immunology research has focused on anti-tumor immunity both systemically and within the tumor microenvironment, little is known about the impact of pre-existing malignancy on pathogen-specific immune responses. Here, we sought to characterize the antigen-specific CD8+ T cell response following a bacterial infection in the setting of pre-existing pancreatic adenocarcinoma. Mice with established subcutaneous pancreatic adenocarcinomas were infected with Listeria monocytogenes, and antigen-specific CD8+ T cell responses were compared to those in control mice without cancer. While the kinetics and magnitude of antigen-specific CD8+ T cell expansion and accumulation was comparable between the cancer and non-cancer groups, bacterial antigen-specific CD8+ T cells and total CD4+ and CD8+ T cells in cancer mice exhibited increased expression of the coinhibitory receptors BTLA, PD-1, and 2B4. Furthermore, increased inhibitory receptor expression was associated with reduced IFN-γ and increased IL-2 production by bacterial antigen-specific CD8+ T cells in the cancer group. Taken together, these data suggest that cancer's immune suppressive effects are not limited to the tumor microenvironment, but that pre-existing malignancy induces phenotypic exhaustion in T cells by increasing expression of coinhibitory receptors and may impair pathogen-specific CD8+ T cell functionality and differentiation.

Citing Articles

Evaluation of Immune Exhaustion and Co-Inhibitory Receptor Expression in Subspecies (MAP) Seropositive Diarrhoeic Bovines.

Sharma S, Sharma K, Kumar R, Dayal D, Dhanda S, Kumar N Pathogens. 2024; 13(6).

PMID: 38921771 PMC: 11206971. DOI: 10.3390/pathogens13060473.


Comprehensive analysis of signaling lymphocyte activation molecule family as a prognostic biomarker and correlation with immune infiltration in clear cell renal cell carcinoma.

Song N, Wang Z, Shi P, Cui K, Fan Y, Zeng L Oncol Lett. 2024; 28(2):354.

PMID: 38881710 PMC: 11176890. DOI: 10.3892/ol.2024.14487.


Signaling lymphocytic activation molecule family receptors as potential immune therapeutic targets in solid tumors.

Gunes M, Rosen S, Shachar I, Gunes E Front Immunol. 2024; 15:1297473.

PMID: 38476238 PMC: 10927787. DOI: 10.3389/fimmu.2024.1297473.


SLAM-family receptors come of age as a potential molecular target in cancer immunotherapy.

Farhangnia P, Ghomi S, Mollazadehghomi S, Nickho H, Akbarpour M, Delbandi A Front Immunol. 2023; 14:1174138.

PMID: 37251372 PMC: 10213746. DOI: 10.3389/fimmu.2023.1174138.


Identification of Potential Prognostic and Predictive Immunological Biomarkers in Patients with Stage I and Stage III Non-Small Cell Lung Cancer (NSCLC): A Prospective Exploratory Study.

Vaes R, Reynders K, Sprooten J, Nevola K, Rouschop K, Vooijs M Cancers (Basel). 2021; 13(24).

PMID: 34944879 PMC: 8699057. DOI: 10.3390/cancers13246259.


References
1.
Khong H, Wang Q, Rosenberg S . Identification of multiple antigens recognized by tumor-infiltrating lymphocytes from a single patient: tumor escape by antigen loss and loss of MHC expression. J Immunother. 2004; 27(3):184-90. PMC: 2275330. DOI: 10.1097/00002371-200405000-00002. View

2.
Motz G, Coukos G . Deciphering and reversing tumor immune suppression. Immunity. 2013; 39(1):61-73. PMC: 3782392. DOI: 10.1016/j.immuni.2013.07.005. View

3.
Danai P, Moss M, Mannino D, Martin G . The epidemiology of sepsis in patients with malignancy. Chest. 2006; 129(6):1432-40. DOI: 10.1378/chest.129.6.1432. View

4.
Ferrone S, Whiteside T . Tumor microenvironment and immune escape. Surg Oncol Clin N Am. 2007; 16(4):755-74, viii. DOI: 10.1016/j.soc.2007.08.004. View

5.
Fox A, Breed E, Liang Z, Clark A, Zee-Cheng B, Chang K . Prevention of lymphocyte apoptosis in septic mice with cancer increases mortality. J Immunol. 2011; 187(4):1950-6. PMC: 3150286. DOI: 10.4049/jimmunol.1003391. View